Login / Signup

Human genetic defects in SRP19 and SRPRA cause severe congenital neutropenia with distinctive proteome changes.

Monika I LinderYoko MizoguchiSebastian HesseGergely CsabaMegumi TatematsuMarcin ŁyszkiewiczNatalia ZietaraTim JeskeMaximilian HastreiterMeino RohlfsYanshan LiuPiotr GrabowskiKaarin AhomaaDaniela Maier-BegandtMarko SchwestkaVahid PazhakhAbdulsalam I IsiakuBrenda Briones MirandaPiers BlomberyMegumu K SaitoEjona RushaZahra AlizadehZahra PourpakMasao KobayashiNima RezaeiEkrem UnalFabian HauckMicha DrukkerBarbara WalzogJuri RappsilberRalf ZimmerGraham J LieschkeChristoph Klein
Published in: Blood (2022)
The mechanisms of coordinated changes in proteome composition and their relevance for the differentiation of neutrophil granulocytes are not well studied. Here, we discover two novel human genetic defects in SRPRA and SRP19, constituents of the mammalian co-translational targeting machinery and characterize their role in neutrophil granulocyte differentiation. We systematically study the proteome of neutrophil granulocytes from patients with variants in the signal recognition particle (SRP) genes, HAX1, and ELANE and identify global as well as specific proteome aberrations. Using in vitro differentiation of human induced pluripotent stem cells and in vivo zebrafish models, we study the effects of SRP-deficiency on neutrophil granulocyte development. In a heterologous cell-based inducible protein expression system, we validate the effects conferred by SRP dysfunction for selected proteins that we identified in our proteome screen. Thus, SRP-dependent protein processing, intracellular trafficking and homeostasis are critically important for the differentiation of neutrophil granulocytes.
Keyphrases